Chlamydia trachomatis is an important cause of postpartum endometritis and neonatal conjunctivitis. However, the prevalence of chlamydial genital infection varies considerably from one population group to another. A study was thus conducted to determine the incidence of C trachomatis infection of the cervix in an unselected group of women attending a Belfast antenatal clinic. One hundred and six patients were screened for evidence of current cervical infection with C trachomatis or serological evidence of past infection. C trachomatis was identified in 2 9%, and there was evidence of past infection in 18 9%. No significant risk factors were identified from gynaecological, contraceptive or sexual histories. C trachomatis infection was treated with erythromycin and there were no perinatal complications ascribed to chlamydia. INTRODUCTION Chlamydia trachomatis is a common sexually transmitted pathogen which may have important implications in pregnancy. It has been proposed as a cause of premature rupture of the membranes," 2 intrauterine growth retardation and preterm delivery.3 Following delivery it may cause endometritis in the mother,4 and conjunctivitis and pneumonitis in the neonate.5 As with other sexually transmitted diseases, the incidence of genital chlamydial infection varies significantly from one geographical area to another, and between population subgroups within a given area. The reported incidence of C trachomatis infection of the cervix in antenatal patients ranges from 2-3% in an unselected group of Dutch women6 to 27% in Baltimore adolescents.7 Relatively few antenatal studies have been performed in the British Isles, and none had previously been undertaken in Northern Ireland. The aims of this study were thus to determine the incidence of current C trachomatis infection of the cervix and the prevalence of past C trachomatis infection in a Belfast antenatal population, and to see if either was associated with adverse pregnancy outcome or postnatal and neonatal morbidity. We also looked
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Chlamydia trachomatis is a common sexually transmitted pathogen which may have important implications in pregnancy. It has been proposed as a cause of premature rupture of the membranes," 2 intrauterine growth retardation and preterm delivery.3 Following delivery it may cause endometritis in the mother, 4 and conjunctivitis and pneumonitis in the neonate. 5 As with other sexually transmitted diseases, the incidence of genital chlamydial infection varies significantly from one geographical area to another, and between population subgroups within a given area. The reported incidence of C trachomatis infection of the cervix in antenatal patients ranges from 2-3% in an unselected group of Dutch women6 to 27% in Baltimore adolescents. 7 Relatively few antenatal studies have been performed in the British Isles, and none had previously been undertaken in Northern Ireland. The aims of this study were thus to determine the incidence of current C trachomatis infection of the cervix and the prevalence of past C trachomatis infection in a Belfast antenatal population, and to see if either was associated with adverse pregnancy outcome or postnatal and neonatal morbidity. We also looked for a correlation between aspects of sexual history and evidence of chlamydial infection to see if there were any indentifiable risk factors. PATIENTS AND METHODS The patients studied were 106 women attending for their antenatal booking visit at Jubilee Maternity Hospital, Belfast, between March and July 1989. A detailed history was taken, including age, parity, number of spontaneous or therapeutic abortions, previous contraceptive usage, history of previous sexually transmitted disease or abnormal cervical cytology, age of first coitus, and number of sexual partners since first coitus. In addition to routine examination, a speculum examination was performed and a dacron -tipped swab was rotated in the endocervix. The swab was then rolled over the centre well of a MicroTrak slide (Syva, UK) which was fixed in acetone. The slides were sent to the regional virology laboratory where the direct fluorescent antibody test was performed. This involves overlaying each slide with fluorescein -labelled monoclonal antibody prior to fluorescent microscopy ( x 40 objective). The presence of 5 or more chlamydia elementary bodies was considered as a positive result. Ten millilitres of blood was also taken from each patient and forwarded to the regional virology laboratory. The serum was stored at -20°C prior to being forwarded in batches to the Institute of Ophthalmology in London, where microimmuno-fluorescence was performed to determine IgG and IgM titres to the D -K serovars of C trachomatis. Verbal consent was obtained for taking the additional samples required for the study. Those in whom the MicroTrak slide was positive were treated with a two -week course of erythromycin 250 mg qid, and their partners were treated concurrently. RESULTS The mean age of the patients was 26 years; 56 were nulliparous and 50 were parous, with a range of parity from 0-7. A history of previous spontaneous abortion was given by 13 -2 %, and 2 -8 % had previously undergone termination of pregnancy. With regard to previous contraceptive usage, 62 -3 % had used the oral contraceptive pill and 2-9% an intrauterine contraceptive device (IUCD); 27-4 % had used barrier methods and 25 -5 % had never used any contraception. Only 3 patients gave a history of previous sexually transmitted disease, and none gave a history of abnormal cervical cytology. The average age at first coitus was 19 years, with a range from 14 -29 years. The distribution of total number of sexual partners is shown in Table 1 . In this study there were few complications of pregnancy and a low incidence of postnatal and neonatal morbidity. This may have been influenced by antenatal treatment of the three infected women. However, other workers who performed studies in which infected mothers were not treated antenatally have also shown no adverse effect on pregnancy outcome.'1-13 In view of this, and the possibility of reinfection, it has been suggested that antenatal screening should be performed between 34 and 38 weeks.14 This should be effective in preventing postnatal and neonatal complications. However, the neonatal complications are generally mild and respond promptly to erythromycin. Thus, in such a low prevalence area as Northern Ireland, and in the absence of identifiable risk factors, the value of routine antenatal screening for C trachomatis is questionable.
